Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2237839rdf:typepubmed:Citationlld:pubmed
pubmed-article:2237839lifeskim:mentionsumls-concept:C0030190lld:lifeskim
pubmed-article:2237839lifeskim:mentionsumls-concept:C0032145lld:lifeskim
pubmed-article:2237839lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:2237839lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:2237839lifeskim:mentionsumls-concept:C1705241lld:lifeskim
pubmed-article:2237839lifeskim:mentionsumls-concept:C0205275lld:lifeskim
pubmed-article:2237839lifeskim:mentionsumls-concept:C1705242lld:lifeskim
pubmed-article:2237839pubmed:issue5lld:pubmed
pubmed-article:2237839pubmed:dateCreated1990-12-20lld:pubmed
pubmed-article:2237839pubmed:abstractTextThe protein conformation of latent and active PAI-1 has been studied with circular dichroism, absorbance and fluorescence spectroscopy. The far ultraviolet circular dichroism spectrum of latent PAI-1 displays a more negative band at 220 nm than active PAI-1, crossing the baseline at a lower wavelength. Active PAI-1 shows an absorption maximum at lower wavelength (269 nm) than present in latent PAI-1 (278 nm). In consistency, slow denaturation of active PAI-1 by incubation for two hours at 37 degrees C induces a shift in the absorption maximum from 268 nm to 274 nm. The fluorescence emission maximum of latent PAI-1 is at lower wavelength (335 nm) than that of active PAI-1 (340 nm). These spectroscopic differences are interpreted as reflecting a more tight conformation, with the tryptophan residues in a more apolar environment, in latent PAI-1 compared to active PAI-1.lld:pubmed
pubmed-article:2237839pubmed:languageenglld:pubmed
pubmed-article:2237839pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2237839pubmed:citationSubsetIMlld:pubmed
pubmed-article:2237839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2237839pubmed:statusMEDLINElld:pubmed
pubmed-article:2237839pubmed:monthSeplld:pubmed
pubmed-article:2237839pubmed:issn0049-3848lld:pubmed
pubmed-article:2237839pubmed:authorpubmed-author:DeinumJJlld:pubmed
pubmed-article:2237839pubmed:authorpubmed-author:WirthMMlld:pubmed
pubmed-article:2237839pubmed:authorpubmed-author:BoströmSSlld:pubmed
pubmed-article:2237839pubmed:authorpubmed-author:KubistaMMlld:pubmed
pubmed-article:2237839pubmed:authorpubmed-author:LöfrothJ EJElld:pubmed
pubmed-article:2237839pubmed:issnTypePrintlld:pubmed
pubmed-article:2237839pubmed:day1lld:pubmed
pubmed-article:2237839pubmed:volume59lld:pubmed
pubmed-article:2237839pubmed:ownerNLMlld:pubmed
pubmed-article:2237839pubmed:authorsCompleteYlld:pubmed
pubmed-article:2237839pubmed:pagination851-8lld:pubmed
pubmed-article:2237839pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2237839pubmed:meshHeadingpubmed-meshheading:2237839-...lld:pubmed
pubmed-article:2237839pubmed:meshHeadingpubmed-meshheading:2237839-...lld:pubmed
pubmed-article:2237839pubmed:meshHeadingpubmed-meshheading:2237839-...lld:pubmed
pubmed-article:2237839pubmed:meshHeadingpubmed-meshheading:2237839-...lld:pubmed
pubmed-article:2237839pubmed:meshHeadingpubmed-meshheading:2237839-...lld:pubmed
pubmed-article:2237839pubmed:meshHeadingpubmed-meshheading:2237839-...lld:pubmed
pubmed-article:2237839pubmed:meshHeadingpubmed-meshheading:2237839-...lld:pubmed
pubmed-article:2237839pubmed:year1990lld:pubmed
pubmed-article:2237839pubmed:articleTitleConformational differences between latent and active plasminogen activator inhibitor, PAI-1: a spectroscopic study.lld:pubmed
pubmed-article:2237839pubmed:affiliationHässle Cardiovascular Research Laboratories, Mölndal, Sweden.lld:pubmed
pubmed-article:2237839pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2237839pubmed:publicationTypeComparative Studylld:pubmed